Recce Pharmaceuticals Eulerpool News

Recce Pharmaceuticals Aktie News

Recce Pharmaceuticals wird von vielen Journalisten und Investoren weltweit beobachtet. Die aktuellsten Recce Pharmaceuticals News stellen wir hier zusammen.

• 27. Februar ·

  Yahoo
  Recce Pharmaceuticals Granted Japanese Patent for RECCE® Anti-Infectives
• 10. Dezember ·

  Yahoo
  Recce Pharmaceuticals Receives Approval from Indonesia’s Drug and Food Authority for Registrational Phase 3 Trial of RECCE® 327 Topical Gel in Diabetic Foot Infections
• 1. Dezember ·

  Yahoo
  Investors in Recce Pharmaceuticals (ASX:RCE) have seen notable returns of 68% over the past five years
• 27. November ·

  Yahoo
  Recce Pharmaceuticals Granted Australia Patent for RECCE® Anti-Infectives
• 12. November ·

  Yahoo
  Recce Pharmaceuticals Receives Ethics Approval in Indonesia to Commence Registrational Phase 3 Trial of RECCE® 327 Topical Gel in Diabetic Foot Infections
• 6. November ·

  Yahoo
  Recce Pharmaceuticals Advances Patient Dosing to Final Stages in Phase II Trial for Acute Bacterial Skin and Skin Structure Infections
• 10. Oktober ·

  Yahoo
  Recce Pharmaceuticals Announces Recruitment Passes Halfway in Phase II Trial for Acute Bacterial Skin and Skin Structure Infections
• 6. August ·

  Yahoo
  Recce Pharmaceuticals Announces Successful Completion of Share Purchase Plan
• 10. Juli ·

  Yahoo
  Recce Pharmaceuticals Announces Positive Preclinical Efficacy Data Against WHO Priority Pathogen Acinetobacter baumannii
• 1. Juli ·

  Yahoo
  Recce Pharmaceuticals Reports Positive Data from Phase I/II Urinary Tract Infection (UTI) / Urosepsis Rapid Infusion Trial of RECCE® 327